Logo1 logo2
Attention Investors
Kindly note the Change in PAY IN for BSE A/C No. : 1201250000000691 (CDSL), if you have an NSDL A/C, kindly use INTER DEPOSITORY SLIP. For assistance, please call OR contact: Mr. Dadu, 98339 89807 / 022-6145 1000.    |   Exchanges / Depository: Prevent Unauthorized Transactions in your Trading / Demat account --> Update your Mobile Numbers / email IDs with your Stock Brokers / Depository Participant. Receive alerts on your Registered Mobile / email IDs for trading account transactions and all debit and other important transactions in your demat account directly from Exchange / Depository on the same day ......................Issued in the interest of Investors."     |    KYC : "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."     |    ASBA-IPO : "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
tiker sep
plus stop minus
 
 
Sun Pharmaceutical Industries LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:524715NSE Symbol: SUNPHARMAP/E(TTM):158.19
ISIN Demat:INE044A01036Div & Yield %:0.82EPS(TTM):12.27
Book Value(Rs):93.2373503Market Cap (rupee Cr.):465710.92Face Value(Rs):1
    Change Company 
(rupee In Cr)
 Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021
INCOME :      
Sales Turnover 20754.6422977.4020275.1720812.1415585.9814116.05
Excise Duty0.000.000.000.000.000.00
Net Sales20754.6422977.4020275.1720812.1415585.9814116.05
Other Income 1776.43634.33553.48329.291196.88192.07
Stock Adjustments 305.8355.14-180.32237.93183.18179.64
Total Income22836.9023666.8720648.3321379.3616966.0414487.76
EXPENDITURE :      
Raw Materials 5774.795776.325423.796292.095833.575287.12
Power & Fuel Cost488.71463.40450.42495.21422.33384.16
Employee Cost 2911.302691.312373.952156.952000.781805.98
Other Manufacturing Expenses 1434.361319.451195.301037.321064.32862.12
Selling and Administration Expenses 5137.655554.084754.864326.423514.053309.62
Miscellaneous Expenses 1036.41645.47615.663257.272086.08479.24
Less: Pre-operative Expenses Capitalised0.000.000.000.000.000.00
Total Expenditure16783.2216450.0314813.9817565.2614921.1312128.24
Operating Profit6053.687216.845834.353814.102044.912359.52
Interest 947.84953.89784.08472.18388.10267.52
Gross Profit5105.846262.955050.273341.921656.812092.00
Depreciation1311.721286.741600.621600.871349.951236.43
Profit Before Tax3794.124976.213449.651741.05306.86855.57
Tax1436.55908.62546.10752.77-553.58244.91
Fringe Benefit tax0.000.000.000.000.000.00
Deferred Tax-265.85-160.4945.37-702.44960.43-231.74
Reported Net Profit2623.424228.082858.181690.72-99.99842.40
Extraordinary Items -321.2510.25-193.46-1665.671237.51-63.64
Adjusted Net Profit2944.674217.833051.643356.39-1337.50906.04
Adjst. below Net Profit -2.74-397.14-19.867.38-14.532675.94
P & L Balance brought forward12948.0112731.0412790.8813612.0815964.5514005.27
Statutory Appropriations 0.000.000.000.000.000.00
Appropriations -1209.603613.972898.162519.302237.951559.06
P & L Balance carried down16778.2912948.0112731.0412790.8813612.0815964.55
Dividend2614.272414.300.000.000.000.00
Preference Dividend0.000.000.000.000.000.00
Equity Dividend %1600.001600.001350.001150.001000.00750.00
Earnings Per Share-Unit Curr10.9317.6211.917.05-0.423.51
Earnings Per Share(Adj)-Unit Curr10.9317.6211.917.05-0.423.51
Book Value-Unit Curr93.2499.6198.7698.98102.48112.28